D.C. Law 21-131. Revised Synthetics Abatement and Full Enforcement Drug Control Temporary Amendment Act of 2016.
AN ACT
To amend, on a temporary basis, the District of Columbia Uniform Controlled Substances Act of 1981 to add certain classes and substances to the list of Schedule I controlled substances.
BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Revised Synthetics Abatement and Full Enforcement Drug Control Temporary Amendment Act of 2016".
Sec. 2. The District of Columbia Uniform Controlled Substances Act of 1981, effective August 5, 1981 (D.C. Law 4-29; D.C. Official Code § 48-901.01 et seq.), is amended as follows:
(a) Section 102 (27) (D.C. Official Code § 48-901.02(27)) is amended as follows:
(1) Strike the phrase "as used in section 204(3) and section 206(1)(D)" and insert the phrase "as used in section 204(3), (5), and (6) and section 206(1)(D)" in its place.
(2) Strike the phrase "As used in section 204(3)" and insert the phrase "As used in section 204(3), (5), and (6)" in its place.
(b) Section 204 (D.C. Official Code § 48-902.04) is amended as follows:
(1) Paragraph (3) is amended as follows:
(A) The lead-in language is amended by striking the phrase "(for purposes of this paragraph only, the term "isomer" includes the optical, position, and geometric isomers)".
(B) New subparagraphs (G-i) through (G-xii) are added to read as follows:
"(G-i) 25I-NBOMe (also known as 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine);
"(G-ii) 25B-NBOMe (also known as 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine);
"(G-iii) 25C-NBOMe (also known as 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine);
"(G-iv) 5-APB (also known as 1-(benzofuran-5-yl)propan-2-amine);
"(G-v) 5-APDB (also known as 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine);
"(G-vi) 6-APB (also known as 1-(1-benzofuran-6-yl)propan-2-amine);
"(G-vii) 6-APDB (also known as1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine);
"(G-viii) 3-methoxy-PCE (also known as N-ethyl-1-(3-methoxyphenyl)cyclohexanamine);
"(G-ix) 3-methoxy-PCP (also known as 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine);
"(G-x) 4-methoxy-PCP (also known as 1-[1-(4-methoxyphenyl)cyclohexyl]piperidine);
"(G-xi) 5-MeO-DALT (also known as N,N-diallyl-5-methoxytryptamine);
"(G-xii) 4-AcO-DMT (also known as 5-acetoxy-N,N-dimethyltryptamine);".
(C) A new subparagraph (M-i) is added to read as follows:
"(M-i) Methoxetamine (also known as 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone);".
(D) Subparagraph (JJ) is amended by striking the word "and".
(E) Subparagraph (KK) is amended by striking the phrase "(2C-P);" and inserting the phrase "(2C-P); and" in its place.
(F) A new subparagraph (LL) is added to read as follows:
"(LL) Cathinone;".
(2) Paragraph (5) is repealed.
(3) A new paragraph (5A) is added to read as follows:
"(5A) Synthetic Cathinones, which includes any material, compound, mixture, or preparation that is not otherwise listed as a controlled substance in this schedule or in Schedules II through V, is not approved by the Food and Drug Administration as a drug, and is structurally derived from or contains any quantity of the following substances, their salts, isomers, homologues, analogues, and salts of isomers, homologues, and analogues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, analogues, and salts of isomers, homologues, and analogues is possible within the specific chemical designation:
"(A) Classified Synthetic Cathinones:
"(i) Any compound containing a 2-amino-1-propanone structure with substitution at the 1-position with a monocyclic or fused polycyclic ring system and a substitution at the nitrogen atom by an alkyl group, cycloalkyl group, or incorporation into a heterocyclic structure. Examples of this structural class include:
"(I) -pyrrolidinopropiophenone, also known as:
"(aa) 1-phenyl-2-(1-pyrrolidinyl)-1-propanone; or
"(bb) α-PPP;
"(II) Dimethylcathinone, also known as:
"(aa) 2-(dimethylamino)-1-phenyl-1-propanone; or
"(bb) N,N-Dimethylcathinone; and
"(III) Ethcathinone, also known as:
"(aa) 2-(ethylamino)-1-phenyl-1-propanone;
"(bb) Ethylcathinone;
"(cc) N-Ethylcathinone; or
"(dd) 2-Ethylaminobuphedro;
"(ii) Any compound containing a 2-amino-1-propanone structure with substitution at the 1-position with a monocyclic or fused polycyclic ring system and a substitution at the 3-position carbon with an alkyl, haloalkyl, or alkoxy group. Examples of this structural class include naphyrone (also known as 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one);
"(iii) Any compound containing a 2-amino-1-propanone structure with substitution at the 1-position with a monocyclic or fused polycyclic ring system and a substitution at any position of the ring system with an alkyl, haloalkyl, halogen, alkylenedioxy, or alkoxy group, whether or not further substituted at any position on the ring system to any extent. Examples of this structural class include:
"(I) 3-fluoromethylone;
"(II) Mephedrone, also known as:
"(aa) 2-(methylamino)-1-(4-methylphenyl)-1-propanone;
"(bb) 4-MeMC;
"(cc) 4-Methylmethcathinone;
"(dd) 4-Methylephedrone; or
"(ee) 4-MMC; and
"(III) Methylone, also known as
"(aa) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)-1-propanone; or
"(bb) 3,4-Methylenedioxy-N-methylcathinone);
"(iv) Any compound containing or structurally derived from a piperazine, or diethylenediamine, structure with or without substitution at one of the nitrogen atoms of the piperazine ring to any extent. Examples include:
"(I) BZP, also known as:
"(aa) 1-(phenylmethyl)-piperazine;
"(bb) 1-Benzylpiperazine; or
"(cc) N-Benzylpiperazine; and
"(II) TMFPP, also known as:
"(aa) 1-[3-(trifluoromethyl)phenyl]-piperazine;
"(bb) 1-(m-Trifluoromethylphenyl) piperazine; or
"(cc) 3-Trifluoromethylphenylpiperazine;
"(B) Unclassified Synthetic Cathinones:
"(i) Aminorex (also known as (RS)-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine);
"(ii) -ET, also known as:
"(I) -ethyl-1H-indole-3-ethanamine;
"(II) -ethyltryptamine; or
"(III) 3-Indolybutylamine;
"(iii) -MT, also known as:
"(I) -methyl-1H-indole-3-ethanamine; or
"(II) -methyltryptamine;
"(iv) α-PBP, also known as:
"(I) 1-phenyl-2-(1-pyrrolidinyl)-1-butanone; or
"(II) -pyrrolidinobutiophenone;
"(v) α-PVP (also known as α-pyrrolidinopentiophenone);
"(vi) bk-MDDMA, also known as:
"(I) 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one;
"(II) Dimethylone;
"(III) N,N-dimethyl-3′,4′-methylenedioxycathinone;
"(IV) N,N-dimethyl-3,4-methylenedioxycathinone; or
"(V) N,N-Dimethyl MDCATH;
"(vii) Buphedrone, also known as:
"(I) 2-(methylamino)-1-phenylbutan-1-one; or
"(II) MABP;
"(viii) Butylone (also known as 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one);
"(ix) 3,4-DMMC, also known as:
"(I) 1-(3,4-dimethylphenyl)-2-(methylamino)-1-propanone;or
"(II) 3,4-Dimethylmethcathinone;
"(x) EMA, also known as:
"(I) N-ethyl-α-methyl-benzeneethanamine; or
"(II) N-Ethylamphetamine;
"(xi) EMC, also known as:
"(I) 1-(4-ethylphenyl)-2-(methylamino)propan-1-one;
"(II) 4-EMC; or
"(III) 4-Ethylmethcathinone;
"(xii) Ethylone, also known as:
"(I) 3,4-Methylenedioxy-N-ethylcathinone; or
"(II) MDEC;
"(xiii) Fenethylline (also known as (RS)-1,3-dimethyl- 7-[2-(1-bpphenylpropan-2-ylamino)ethyl]purine-2,6-dione);
"(xiv) Fluoromethcathinone (also known as 1-(4-fluorophenyl)-2-(methylamino) propan-1-one);
"(xv) 3-FMC (also known as 3-fluoro-N-methylcathinone);
"(xvi) 4-FMC, also known as:
"(I) 1-(4-fluorophenyl)-2-(methylamino)propan-1-one;
"(II) 4-fluoro-N-methylcathinone; or
"(III) Flephedrone;
"(xvii) MDPBP, also known as:
"(I) 1-(1,3-benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-butanone; or
"(II) 3,4-Methylenedioxy-α-Pyrrolidinobutiophenone;
"(xviii) MDPPP, also known as:
"(I) 1-(1,3-benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-propanone; or
"(II) 3,4-Methylenedioxy-α-Pyrrolidinopropiophenone;
"(xix) MDPV, also known as:
"(I) 1-(1,3-benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone; or
"(II) 3,4-Methylenedioxy Pyrovalerone;
"(xx) 4-MeBP, also known as:
"(I) 2-(methylamino)-1-(4-methylphenyl)-1-butanone;
"(II) 4-Methylbuphedrone;
"(III) 4-methyl BP; or
"(IV) 4-MeMABP
"(xxi) 3-MEC, also known as:
"(I) 2-(ethylamino)-1-(m-tolyl)propan-1-one; or
"(II) 3-Methyl-N-ethylcathinone;
"(xxii) 4-MEC, also known as:
"(I) 2-(ethylamino)-1-(4-methylphenyl)-1-propanone; or
"(II) 4-Methyl-N-ethylcathinone;
"(xxiii) 4-MePPP, also known as
"(I) 4'-methyl-α-Pyrrolidinopropiophenone;
"(II) 4'-methyl PPP; or
"(III) 2-(pyrrolidin-1-yl)-1-(p-tolyl)propan-1-one;
"(xxiv) 3-MMC, also known as:
"(I) 2-(methylamino)-1-(3-methylphenyl)-1-propanone;
"(II) 3-methyl MS; or
"(III) 3-Methylmethcathinone;
"(xxv) Methedrone (also known as 1-(4-methoxyphenyl)-2-(methylamino)-1-propanone);
"(xxvi) 4′-methyl PHP, also known as:
"(I) 4′-methyl-α-pyrrolidinohexanophenone;
"(II) MPHP;
"(III) 4'-methyl- α-PHP; or
"(IV) PV4;
"(xxvii) Naphyrone, also known as:
"(I) 1-(2-naphthalenyl)-2-(1-pyrrolidinyl)-1-pentanone; or
"(II) Naphpyrovalerone;
"(xxviii) N-hydroxy MDA, also known as:
"(I) MDOH;
"(I) N-hydroxy-α-methyl-1,3-benzodioxole-5-ethanamine;or
"(II) N-Hydroxy-3,4-methylenedioxyamphetamine;
"(xxix) N,N-DMA, also known as:
"(I) N,N,α-trimethyl-benzeethanamine;
"(II) N,N-Dimethylamphetamine;
"(III) Dimetamfetamine; or
"(III) Metrotonin;
"(xxx) Pentedrone (also known as 2-(methylamino)-1-phenylpentan-1-one); and
"(xxxi) Pentylone (also known as 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one);".
(4) A new paragraph (6) is added to read as follows:
"(6) Synthetic Cannabimimetic Agents (also known as synthetic cannabinoids), which includes, unless specifically exempted, unless listed in another schedule, or unless approved by the Food and Drug Administration as a drug, any material, mixture, preparation, any compound structurally derived from, or that contains any quantity of the following synthetic substances, their salts, isomers, homologues, analogues and salts of isomers, homologues, and analogues, whenever the existence of these salts, isomers, homologues, analogues, and salts of isomers, homologues, and analogues is possible within the specific chemical designation:
"(A) Classified Synthetic Cannabimimetic Agents:
"(i) Adamantanoylindoles: Any compound containing or structurally derived from an adamantanyl-(1H-indol-3-yl)methanone structure with or without substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent. Examples include:
"(I) AB-001, also known as:
"(aa) (1s,3s)-adamantan-1-yl(1-pentyl-1H-indol-3-yl)methanone; or
"(bb) JWH 018 adamantyl analog; and
"(II) AM-1248, also known as:
"(aa) [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]tricyclo[3.3.1.13,7]dec-1-yl-methanone; or
"(bb) AM1248;
"(ii) Adamantoylindazoles: or any compound containing or structurally derived from 3-(1-adamantoyl) indole, 3-(1-adamantoyl)indazole, 3-(2-adamantoyl)indole, N-(1-adamantyl)-1H-indole-3-carboxamide, or N-(1-adamantyl)-1H-indazole-3-carboxamide by substitution at the nitrogen atom of the indole or indazole ring with alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole or indazole ring to any extent and whether or not substituted in the adamantyl ring to any extent. This category includes adamantyl carboxamide indazoles;
"(iii) Adamantylamidoindoles: Any compound containing or structurally derived from an N-(adamantyl)-indole-3-carboxamide structure, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring to any extent;
"(iv) Adamantylindazoles: Any compound containing or structurally derived from an N-(adamantyl)-indazole-3-carboxamide structure with substitution at a nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent, whether or not substituted on the adamantyl ring to any extent. Examples include:
"(I) 5F-APINACA, also known as:
"(aa) 5-fluoro-APINACA
"(bb) 5F-AKB-48;
"(cc) 5F-AKB48;
"(dd) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide; or
"(ee) N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide); and
"(II) APINACA, also known as:
"(aa) AKB-48;
"(bb) AKB48;
"(cc) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide; or
"(dd) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide;
"(v) Adamantylindoles: Any compound containing or structurally derived from an N-(adamantyl)-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, and whether or not substituted on the adamantyl ring to any extent. Examples include:
"(I) 2NE1, also known as:
"(aa) APICA;
"(bb) JWH 018 adamantyl carboxamide; or
"(cc) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide;
"(II) Adamantyl carboxamide indoles; and
"(III) STS-135, also known as:
"(aa) 1-(5-fluoropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide;
"(bb) N-adamantyl-1-fluoropentylindole-3-Carboxamide;
"(cc) 5F-APICA; or
"(dd) 5-fluoro-APICA;
"(vi) Benzimidazole Ketone: Any compound containing or structurally derived from (benzimidazole-2-yl) methanone structure with or without substitution at either nitrogen atom of the benzimidazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, with substitution at the carbon of the methanone group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl, cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3, 3-dimethyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3, 3-dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not further substituted in the benzimidazole, adamantyl, naphthyl, phenyl, pyrrole, quinolinyl, or cycloalkyl rings to any extent. Benzimidazole Ketones include:
"(I) FUBIMINA, also known as:
"(aa) (1-(5-fluoropentyl)-1H-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone; or
"(bb) AM2201 benzimidazole analog; and
"(II) JWH-018 benzimidazole analog, also known as:
"(aa) naphthalen-1-yl(1-pentyl-1H-benzo[d]imidazol-2-yl)methanone; or
"(bb) BIM-018;
"(vii) Benzoylindoles: Any compound containing or structurally derived from a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Examples include:
"(I) AM-630, also known as:
"(aa) [6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)-methanone;
"(bb) AM630; or
"(cc) Iodopravadoline ;
"(II) AM-661 (also known as 1-(N-methyl-2-piperidine)methyl-2-methyl-3-(2-iodo)benzoylindole);
"(III) AM-679, also known as:
"(aa)(2-iodophenyl)(1-pentyl-1H-indol-3yl) methanone; or
"(bb) AM679;
"(IV) AM-694, also known as:
"(aa) [1-(5-fluoropentyl)-1H-indol-3-yl](2-iodophenyl)-methanone;
"(bb) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole;or
"(cc) AM694;
"(V) AM-1241, also known as:
"(aa)(2-iodo-5-nitrophenyl) -(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone; or
"(bb) AM1241;
"(VI) AM-2233, also known as:
"(aa)(2-iodophenyl) [1-[(1-methyl-2piperidinyl)methyl]-1H-indol-3-yl]-methanone; or
"(bb) AM2233;
"(VII) RCS-4, also known as:
"(aa)(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl) methanone; or
"(bb) SR-19; and
"(VIII) WIN 48,098, also known as
"(aa)(4-methoxyphenyl) [2-methyl]-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-methanone; or
"(bb) "Pravadoline";
"(viii) Carbazole Ketone: Any compound containing or structurally derived from (9H-carbazole-3-yl) methanone structure with or without substitution at the nitrogen atom of the carbazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group with substitution at the carbon of the methanone group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl, cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3, 3-dimethyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3, 3-dimethyl-1-oxobutan-2-yl or pyrrole group, and whether or not further substituted at the carbazole, adamantyl, naphthyl, phenyl, pyrrole, quinolinyl, or cycloalkyl rings to any extent. Carbazole Ketones include naphthalen-1-yl(9-pentyl-9H-carbazol-3-yl)methanone ("EG-018");
"(ix) Carboxamideindazoles: Any compound containing or structurally derived from 3-carboxamide-1H-indazoles, whether or not substituted in the indazole ring to any extent and substituted to any degree on the carboxamide nitrogen and 3-carboxamide-1H-indoles, whether or not substituted in the indole ring to any extent and substituted to any degree on the carboxamide nitrogen. Examples include:
"(I) AB-CHMINACA (also known as N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);
"(II) AB-FUBINACA (also known as N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide);
"(III) AB-PINACA (also known as N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide);
"(IV) 5F AB-PINACA, also known as:
"(aa) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide); or
"(bb) 5-fluoro AB-PINACA;
"(V) ADB-FUBINACA (also known as N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1-H-indazole-3-carboxamide);
"(VI) ADB-PINACA (also known as N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide);
"(VII) 5F ADB-PINACA, also known as:
"(aa) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1(5-fluoropentyl)-1H-indazole-3-carboxamide); or
"(bb) 5-fluoro ADB-PINACA;
"(VIII) FUB-AMB, also known as:
"(aa) methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate; or
"(bb) AMB-FUBINACA;
"(IX) MAB-CHMINACA (also known as N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);
"(X) MMB CHMINACA, also known as:
"(aa) methyl (S)-2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate; or
"(bb) MDMB-CHMICA; and
"(XI) 5F MN-18, also known as:
"(aa) 1-(5-fluoropentyl)-N-1-naphthalenyl-1H-indazole-3-carboxamide; or
"(bb) 5-fluoro MN-18;
"(x) Cycloalkanemethanone Indoles: whether or not substituted at the nitrogen atom on the indole ring, whether or not further substituted in the indole ring to any extent, and whether or not substituted on the cycloalkane ring to any extent;
"(xi) Cyclohexylphenols: Any compound containing or structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the cyclohexyl ring to any extent. Examples include:
"(I) CP 47,497 (also known as 2-[(1S,3R)-3-hydroxycyclohexyl]- 5-(2-methyloctan-2-yl)phenol);
"(II) CP 47,497 C8 homologue, also known as:
"(aa) rel-2-[(1S,3R)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol; or
"(bb) Cannabicyclohexanol;
"(III) CP 55,490;
"(IV) CP 55,940 (also known as 5-(1,1-dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-phenol); and
"(V) CP 56,667;
"(xii) Cyclopropanoylindoles: Any compound containing or structurally derived from 3-(cyclopropylmethanoyl)indole, 3-(cyclopropylmethanone)indole, 3-(cyclobutylmethanone)indole or 3-(cyclopentylmethanone)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, and whether or not substituted on the cyclopropyl, cyclobutyl, or cyclopentyl rings to any extent;
"(xiii) Cyclopropylmethanone Indole: Any compound containing or structurally derived from 3-Cyclopropylmethanone indole or 3-Cyclobutylmethanone indole or 3-Cyclopentylmethanone indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent andwhether or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl rings to any extent;
"(xiv) Hexahydrodibenzopyrans: Any compound containing or structurally derived from Hexahydrodibenzopyrans, whether or not substituted in the tricyclic ring system except where contained in cannabis or cannabis resin;
"(xv) Hydroxycyclohexylphenol: Any compound containing or structurally derived from 2-(3-hydroxycyclohexyl)phenol structure, also known as cyclohexylphenols, with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted on the cyclohexyl ring to any extent. Examples of this structural class include:
"(I) CP-47,497 (also known as rel-5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol);
"(II) CP 47,497-C8-homolog, also known as:
"(aa) rel-2-[(1S,3R)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol; or
"(bb) cannabicyclohexanol; and
"(III) CP-55,940 (also known as 2-((1S,2S,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2-methyloctan-2-yl)phenol);
"(xvi) Indazole Ester (also known as carboxylateindazole): Any compound containing or structurally derived from 3-carboxylate-indazoles, whether or not substituted in the indazole ring to any extent or substituted to any degree on the carboxylate, whether or not substituted in the indazole ring to any extent and substituted to any degree on the carboxylate oxygen. Examples of indazole esters include 5-fluoro SDB-005, also known as:
"(I) naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate; or
"(II) 5F SDB-005;
"(xvii) Indole Amides: Any compound containing or structurally derived from or containing a 1H-Indole-3-carboxamide structure with or without substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, whether or not substituted at the carboxamide group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl, cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3, 3-dimethyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3, 3-dimethyl-1-oxobutan-2-yl or pyrrole group and whether or not further substituted in the indole, adamantyl, naphthyl, phenyl, pyrrole, quninolinyl, or cycloalkyl rings to any extent. Indole Amides include:
"(I) 5F ABICA, also known as:
"(aa)(S) -N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide;
"(bb) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide; or
"(cc) 5-fluoro ABICA;
"(II) ADBICA (also known as N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide));
"(III) 5F-ADBICA, also known as:
"(aa) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide; or
"(bb) 5-fluoro-ADBICA;
"(IV) NNE1 (also known as N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide);
"(V) 5F-NNE1, also known as:
"(aa) 1-(5-fluoropentyl)-N-(naphthalene-1-yl)-1H-indole-3-carboxamide); or
"(bb) 5-fluoro-NNE1
"(VI) SDB-006 (also known as N-benzyl-1-pentyl-1H-indole-3-carboxamide); and
"(VII) 5F-SDB-006, also known as:
"(aa) N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide); or
"(bb) 5-fluoro-SDB-006;
"(xviii) Indole Esters: Any compound containing or structurally derived from a 1H-Indole-3-carboxylate structure with or without substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, whether or not substituted at the carboxylate group by an adamantyl, naphthyl, phenyl, benzyl, quinolinyl, cycloalkyl, 1-amino-3-methyl-1-oxobutan-2-yl, 1-amino-3, 3-dimethyl-1-oxobutan-2-yl, 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-methoxy-3, 3-dimethyl-1-oxobutan-2-yl or pyrrole group and whether or not further substituted in the indole, adamantyl, naphthyl, phenyl, pyrrole, quinolinyl, or cycloalkyl rings to any extent. Indole Esters may also be referred to as Quinolinylindolecarboxylates. Indole Esters include:
"(I) BB-22, also known as:
"(aa) 1-(cyclohexylmethyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid;
"(bb) quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate; or
"(cc) QUCHIC;
"(II) FDU-PB-22 (also known as naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate);
"(III) FUB-PB-22, also known as:
"(aa) 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 8-quinolinyl ester; or
"(bb) Quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate;
"(IV) NM2201, also known as:
"(aa) naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; or
"(bb) CBL-2201;
"(V) PB-22, also known as:
"(aa) 1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid;
"(bb) quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate;
"(cc) 8-Quinolinyl 1-pentyl-1H-indole-3-carboxylate; or
"(dd) "QUPIC"; and
"(VI) 5F-PB-22, also known as:
"(aa) 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid;
"(bb) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate;
"(cc) 8-Quinolinyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate;
"(dd) 5-fluoro-PB-22; or
"(ee) 5-fluoro QUPIC;
"(xix) Naphthoylindoles: Any compound containing or structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl group, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the naphthyl ring to any extent. Napthoylindoles include the following: AM-678, AM-1220, AM-1221, AM-1235, AM-2232, EAM-2201, JWH-004, JWH-007, JWH-009, JWH-011, JWH-015, JWH-016, JWH-018, JWH-019, JWH-020, JWH-022, JWH-046, JWH-047, JWH-048, JWH-049, JWH-050, JWH-070, JWH-071, JWH-072, JWH-073, JWH-076, JWH-079, JWH-080, JWH-081, JWH-082, JWH-094, JWH-096, JWH-098, JWH-116, JWH-120, JWH-122, JWH-148, JWH-149, JWH-164, JWH-166, JWH-180, JWH-181, JWH-182, JWH-189, JWH-193, JWH-198, JWH-200, JWH-210, JWH-211, JWH-212, JWH-213, JWH-234, JWH-235, JWH-236, JWH-239, JWH-240, JWH-241, JWH-242, JWH-258, JWH-262, JWH-386, JWH-387, JWH-394, JWH-395, JWH-397, JWH-398, JWH-399, JWH-400, JWH-412, JWH-413, JWH-414, JWH-415, JWH-424, MAM-2201, WIN 55,212. Napthoylindoles also include:
"(I) AM-2201 (also known as (1-(5-fluoropentyl)-3-(1-naphthoyl)indole); and
"(II) WIN 55,212-2, also known as: *
"(aa)(R) -(+)-[2,3-dihydro-5-methyl-3- (4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone; or
"(bb) [2,3-Dihydro-5-methyl- 3-(4-morpholinylmethyl)pyrrolo[(1,2,3-de)-1,4-benzoxazin-6-yl]-1-napthalenylmethanone);
"(xx) Naphthoylnaphthalenes: Any compound containing or structurally derived from naphthalene-1-yl-(naphthalene-1-yl) methanone with substitutions on either of the naphthalene rings to any extent, including CB-13 (also known as 1-naphthalenyl[4-(pentylox)-1-naphthalenyl]-methanone or CRA-13);
"(xxi) Naphthoylpyrroles: Any compound containing or structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including the following: JWH-030, JWH-031, JWH-145, JWH-146, JWH-147, JWH-150, JWH-156, JWH-243, JWH-244, JWH-245, JWH-246, JWH-292, JWH-293, JWH-307, JWH-308, JWH-309, JWH-346, JWH-348, JWH-363, JWH-364, JWH-365, JWH-367, JWH-368, JWH-369, JWH-370, JWH-371, JWH-373, JWH-392;
"(xxii) Naphthylamidoindoles: Any compound containing or structurally derived from a N-(naphthyl)-indole-3-carboxamide structure, whether or not further substituted in the indole ring to any extent or whether or not substituted in the naphthyl ring to any extent;
"(xxiii) Naphthylmethylindenes: Any compound containing or structurally derived from a 1-(1-naphthylmethylene)indene structure with or without substitution at the 3-position of the indene ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, whether or not further substituted on the indene group to any extent, and whether or not substituted on the naphthyl group to any extent. Naphthylmethylindenes include JWH-176 (also known as 1-[(E)-(3-pentyl-1H-inden-1-ylidene)methyl]-naphthalene or (1-(3-pentyl)-1H-inden-1-ylidene)methylnaphthalene);
"(xxiv) Naphthylmethyl indoles: Any compound containing or structurally derived from 1H-indol-3-yl-(1-naphthyl)methane structure, also known as napthylme-thylindoles, with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent. Examples of this structural class include:
"(I) JWH-175 (also known as 3-(1-naphthalenylmethyl)-1-pentyl-1H-indole); and
"(II) JWH-184 (also known as 3-[(4-methyl-1-naphthalenyl)methyl]-1-pentyl-1H-indole);
"(xxv) Naphthylmethylindenes: Any compound containing or structurally derived from a naphthylideneindene structure or that is structurally derived from 1-(1-naphthylmethyl)indene with substitution at the 3-position of the indene ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent. Examples include JWH-171, JWH-176, and JWH-220;
"(xxvi) Naphthylmethylindoles: Any compound containing or structurally derived from an H-indol-3-yl-(1-naphthyl) methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Examples include JWH-175, JWH-184, JWH-185, JWH-192, JWH-194, JWH-195, JWH-196, JWH-197, and JWH-199;
"(xxvii) Phenylacetylindoles: Any compound containing or structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Examples include: JWH-167, JWH-201, JWH-202, JWH-203, JWH-204, JWH-205, JWH-206, JWH-207, JWH-208, JWH-209, JWH-237, JWH-248, JWH-249, JWH-250, JWH-251, JWH-253, JWH-302, JWH-303, JWH-304, JWH-305, JWH-306, JWH-311, JWH-312, JWH-313, JWH-314, JWH-315, JWH-316, RCS-8, SR-18, and Cannabipiperidiethanone (also known as 2-(2-methoxyphenyl)-1-[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-ethanone);
"(xxviii) Quinolinoyl Pyrazole: Any compound containing or structurally derived from Quinolinoyl pyrazole carboxylate (also known as Quinolinyl fluoropentyl fluorophenyl pyrazole carboxylate);
"(xxix) Quinolinyl Ester Indoles: Any compound containing or structurally derived from Quinolinyl ester indoles, being any compound containing or structurally derived from 1H-indole-3carboxylic acid-8-quinolinyl ester, whether or not substituted in the indole ring to any extent or the quinolone ring to any extent;
"(xxx) Tetrahydrobenzochromen: Any compound containing or structurally derived from (6aR,10aR)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol. Examples of this structural class include:
"(I) AM-087 (also known as (6aR,10aR)-3-(2-methyl-6-bromohex-2-yl)- 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol);
"(II) AM-411 (also known as (6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol);
"(III) HU-210, also known as:
"(aa) 3-(1,1'-dimethylheptyl)-6aR,7,10,10aR-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol;
"(bb) [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- tetrahydrobenzo[c]chromen-1-ol;
"(cc) 1,1-Dimethylheptyl-11-hydroxytetrahydrocannabinol; or
"(dd) 1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol;
"(IV) HU-211, also known as:
"(aa) 3-(1,1-dimethylheptyl)-6aS,7,10,10aS-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol;
"(bb) (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
"(cc) (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; or
"(dd) "Dexanabinol";
"(V) HU-243, also known as:
"(aa) (6aR,8S,9S,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-1-ol; or
"(bb) 3-dimethylheptyl-11-hydroxyhexahydrocannabinol;
"(VI) JWH-051 (also known as (6aR,10aR)-6,6-dimethyl-3- (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-9-yl)methanol);
"(VII) JWH-133 (also known as (6aR,10aR)-3-(1,1-Dimethylbutyl) -6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran); and
"(VIII) JWH-359 (also known as (6aR,10aR)- 1-methoxy-6,6,9-trimethyl- 3-[(2R)-1,1,2-trimethylbutyl]- 6a,7,10,10a-tetrahydrobenzo[c]chromene);
"(xxxi) Δ8 Tetrahydrocannabinol: Any compound containing or structurally derived from 11-hydroxy-Δ8-tetrahydrocannabinol structure, also known as dibenzopyrans, with further substitution on the 3-pentyl group by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkyethyl, 1-(n-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group;
"(xxxii) Tetrahydrodibenzopyrans: Any compound containing or structurally derived from whether or not substituted in the tricyclic ring system except where contained in cannabis or cannabis resin;
"(xxxiii) Tetramethylcyclopropanoylindoles: Any compound containing or structurally derived from 3-tetramethylcyclopropanoylindole, 3-(1 tetramethylcyclopropyl)indole, 3-(2,2,3,3-tetramethylcyclopropyl)indole or 3-(2,2,3,3-tetramethylcyclopropylcarbonyl)indole with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropanoyl ring to any extent. Tetramethylcyclopropanoylindoles include cyclopropoylindoles, any compound containing or structurally derived from a 3-(cyclopropoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, halobenzyl,1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,1-(N-methyl-2-pyrrolidinyl)methyl,1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, 1-methylazepanyl, phenyl, or halophenyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the cyclopropoyl ring to any extent. Examples of tetramethylcyclopropanoylindoles include:
"(I) A-796,260, also known as:
"(aa) [1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone; or
"(bb) A-796260;
"(II) A-834,735, also known as:
"(aa) [1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone; or
"(bb) A-834735;
"(III) AB-034 (also known as [1-[(N-methylpiperidin-2-yl)methyl]-1H-indole-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone);
"(IV) UR-144 (also known as 1-pentyl-3-(2, 2, 3, 3-tetramethylcyclopropoyl)indole);
"(V) 5-bromo-UR-144, also known as:
"(aa) [1-(5-bromopentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone; or
"(bb) UR-144 N-(5-bromopentyl) analog;
"(VI) 5-chloro-UR-144, also known as:
"(aa) 1-(5-chloropentyl)-3-(2, 2, 3, 3-tetramethylcyclopropoyl)indole; or
"(bb) 5Cl-UR-144; and
"(VII) XLR11, also known as:
"(aa) 1-(5-fluoropentyl)-3-(2,2,3, 3-tetramethylcyclopropoyl)indole;
"(bb) 5-FUR-144; or
"(cc) 5-fluoro UR-144;
"(xxxiv) Tetramethylcyclopropane-Thiazole Carboxamides: Any compound containing or structurally derived from 2,2,3,3-tetramethyl-N-(thiazol-2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen atom of the thiazole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or not further substituted in the thiazole ring to any extent and whether or not substituted in the tetramethylcyclopropyl ring to any extent. Examples of tetramethylcyclopropane-thiazole carboxamides include the group tetramethylcyclopropyl thiazoles, or any compound containing or structurally derived from 2,2,3,3-tetramethyl-N-(thiazol- 2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen atom of the thiazole ring, whether or not further substituted in the thiazole ring to any extent, whether or not substituted in the tetramethylcyclopropyl ring to any extent. Tetramethylcyclopropane-thiazole carboxamides also include A-836,339, also known as:
"(I) [N(Z)]-N-[3-(2-methoxyethyl)-4,5-dimethyl-2(3H)-thiazolylidene]-2,2,3,3-tetramethyl-cyclopropanecarboxamide;
"(II) N-[3-(2-Methoxyethyl)-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene]-2,2,3,3-tetramethylcyclopropanecarboxamide: or
"(III) A-836339;
"(B) Unclassified Synthetic Cannabimimetic Agents:
"(i) AM-356, also known as:
"(I) AM356;
"(II) arachidonyl-1'-hydroxy-2'-propylamide;
"(III) N-(2-hydroxy-1R-methylethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide
"(IV)(R) -(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide;
"(V) Methanandamide; or
"(VI) R-1 Methanandamide;
"(ii) AM-855 (also known as (4aR,12bR)-8-hexyl-2,5,5-trimethyl-1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol);
"(iii) AM-905 (also known as (6aR,9R,10aR)-3-[(E)-hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol);
"(iv) AM-906 (also known as (6aR,9R,10aR)-3-[(Z)-hept-1-enyl]9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol);
"(v) AM-2389 (also known as (6aR,9R,10aR)-3-(1-hexyl-cyclobut-1-yl) -6a,7,8,9,10,10a - hexahydro -6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9-diol);
"(vi) BAY38-7271 (also known as (-)-(R)-3-(2-Hydroxymethylindanyl -4-oxy) phenyl-4,4,4-trifluorobutyl-1-sulfonate);
"(vii) CP 50,556-1, also known as:
"(I) 9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]acetate;
"(II) [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-; octahydrophenanthridin-1-yl] acetate;
"(III) [9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10, 10a-octahydrophenanthridin-1-yl]acetate; or
"(IV) "Levonantradol";
"(viii) FUB-144 (also known as (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone);
"(ix) FUB-AMB, also known as:
"(I) AMB-FUBINACA; or
"(II) Methyl (1-(4-fluorobenzyl)-1 H-indazole-3-carbonyl) valinate; and
"(x) 5-fluoro-AMB (also known as (S)- methyl 2- (1- (5-fluoropentyl)- 1H- indazole- 3-carboxamido)- 3- methylbutanoate);
"(xi) HU-308 (also known as (91R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol);
"(xii) HU-331 (also known as 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione);
"(xiii) JTE-907 (also known as N-(benzol[1,3]dioxol-5-ylmethyl) –7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide);
"(xiv) JWH-057 (also known as (6aR,10aR)-3-(1,1-dimethylheptyl) -6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-Dibenzo[b,d]pyran);
"(xv) Mepirapim (also known as (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl) Methanone);
"(xvi) URB597 (also known as [3-(3-carbamoylphenyl)phenyl] –N-Cyclohexylcarbamate);
"(xvii) URB602, also known as:
"(I) [1,1'-Biphenyl]-3-yl-carbamic acid, cyclohexyl ester; or
"(II) cyclohexyl [1,1'-biphenyl]-3-ylcarbamate;
"(xviii) URB754 (also known as 6-methyl-2-[(4-methylphenyl)amino] -4H-3,1-benzoxazin-4-one);
"(xix) URB937 (also known as 3'-carbamoyl-6-hydroxy-[1,1'-biphenyl]-3-yl Cyclohexylcarbamate);
"(xx) SDB-006 (also known as N-benzyl-1-pentyl-1H-indole-3-carboxamide);
"(xxi) THJ-2201 (also known as [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone); and
"(xxii) THJ-018 (also known as Naphthalen-1-yl(1-pentyl-1H-indazol-3-yl)methanone).".
(c) Section 208(a)(7) (D.C. Official Code § 48-902.08(a)(7)) is repealed.
Sec. 3. Fiscal impact statement.
The Council adopts the fiscal impact statement of the Chief Financial Officer as the fiscal impact statement required by section 4a of the General Legislative Procedures Act of 1975, approved October 16, 2006 (120 Stat. 2038; D.C. Official Code § 1-301.47a).
Sec. 4. Effective date.
(a) This act shall take effect following approval by the Mayor (or in the event of veto by the Mayor, action by the Council to override the veto), a 30-day period of congressional review as provided in section 602(c)(1) of the District of Columbia Home Rule Act, approved December 24, 1973 (87 Stat. 813; D.C. Official Code § 1-206.02(c)(1)), and publication in the District of Columbia Register.
(b) This act shall expire after 225 days of its having taken effect.
